Apollon Wealth Management, LLC
Position in CRSP — CRISPR Therapeutics AG
CIK 1764387
MOUNT PLEASANT, SC
Position in CRSP
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$371,378
-$28,844 QoQ
Shares Held
7,807
+2.3% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Apollon Wealth Management, LLC holds $22,162,227 across 13 Biotechnology names. CRSP ranks #4 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
38,595 | $17,234,211 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,831 | $2,959,983 | |
| 3 | PTCT |
Ptc Therapeutics, Inc.
|
7,339 | $500,006 | |
| 4 | CRSP |
CRISPR Therapeutics AG
This page
|
7,807 | $371,378 | |
| 5 | MRNA |
Moderna, Inc.
|
6,842 | $347,573 | |
| 6 | HURA |
TuHURA Biosciences, Inc./NV
|
158,010 | $282,837 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
767 | $253,777 | |
| 8 | FLNA |
Filana Therapeutics, Inc.
|
35,053 | $59,239 |
All Filings in CRSP
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $371,378 | 7,807 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $400,222 | 7,632 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $446,216 | 6,885 | Shares | Sole | 2025-10-17 | |
| 2021-12-31 | $398,527 | 5,259 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||